Ottawa – December 1 marks World AIDS Day and the beginning of Indigenous AIDS Awareness Week. We remember those we lost to human immunodeficiency virus (HIV) and recognize the strength and resilience of those living with HIV. This year’s global theme “Let Communities Lead” acknowledges the fundamental role that community organizations play in supporting those at risk of, or affected by, HIV. The Government …
Eli Lilly to Open 1st Gateway Labs Site in San Diego
INDIANAPOLIS – Eli Lilly and Company (NYSE: LLY) today announced plans to open its first-ever Lilly Gateway Labs location in San Diego, Calif. in the first half of 2024. Gateway Labs is Lilly’s shared innovation accelerator that provides participating companies with state-of-the-art lab space and unique access to Lilly scientists, researchers and executives, as well as exposure to Lilly’s functional and scientific expertise. This will be the company’s third Gateway Labs location, with additional …
Truqap (capivasertib) plus Faslodex approved in the US
London – AstraZeneca’s Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been approved in the US for the treatment of adult patients with hormone receptor (HR)-positive, HER2-negative locally advanced or metastatic breast cancer with one or more biomarker alterations (PIK3CA, AKT1 or PTEN). Eligible patients will have progressed on at least one endocrine-based regimen in the metastatic setting or experienced recurrence …
AstraZeneca launches Evinova
London – AstraZeneca has launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. With long-term backing from AstraZeneca and strategic collaborations with Parexel and Fortrea, Evinova offers globally-scaled digital products and services to the life sciences and healthcare sector. Evinova will prioritise bringing to market established …
Supporting projects to prevent substance use-related harm in youth
Public Health Agency of Canada launches national call for proposals under new youth substance use prevention program Ottawa – Communities across the country have been touched by the unrelenting and tragic toxic drug and overdose crisis. Many young people across Canada continue to face challenges with substance use. The Government of Canada continues to take urgent action to help save …
TPH seeks $3.8M for routine school-aged vaccination programs
Toronto – Toronto Public Health (TPH) presented ongoing vaccination rate challenges among school-aged children to the Board of Health, a concern intensified by pandemic-related disruptions. The board adopted the recommendation that Toronto’s Medical Officer of Health, Dr. Eileen de Villa, seek $3.8 million from the Ministry of Health to address gaps identified in a recent Public Health Ontario report. The …
Seek advise before taking Ozempic in weight loss obsession
Australia – People who put on a lot of weight try to find ways to shed those pounds and take any drastic step to do so. A woman in Australia lost life after Ozempic has become a thing on social media as people are taking the drug after it was rumoured that influencers and celebrities were taking it to control …
All about Parkinson implants
Paris – A unique implant that stimulates the nerves in the spinal cord’s lumbar area, sending signals to the muscles in the legs, has helped a man walk again despite having severe Parkinson’s disease. The medical staff attending to him writes about the breakthrough in the journal Nature Medicine.
UK advised to add chickenpox shot to child immunisation plan
London – The British government has been advised to include the chickenpox vaccine in its routine childhood immunisation programme, the UK’s vaccine advisory body said for the first time decades after the shots were made widely available in several other nations. If the government accepts the recommendation, it will bring the nation in line with several other countries — including …
Lilly to expand injectable manufacturing capacity in Germany
Company also commits to investing up to $100 million in German early-stage life sciences ecosystem INDIANAPOLIS – Eli Lilly and Company (NYSE: LLY) has announced plans to construct a new $2.5 billion high-tech manufacturing site in Alzey, Rhineland-Palatinate, Germany. This new facility will further expand the company’s global parenteral (injectable) product and device manufacturing network and support an increased demand for Lilly’s …